Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.
Press releases published on May 20, 2025
Gnosko Launches RFID-Integrated Chain of Custody Platform to Help Labs Do More with Less
EIN Presswire
·
May 20, 2025
Gnosko launches a RFID Chain of Custody platform, helping labs automate tracking and compliance amid budget cuts. BRYN MAWR, PA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- As laboratories face shrinking research budgets, government funding cuts, …
Language Services Associates Named Philadelphia Inquirer Top Workplace – Three Years Running
EIN Presswire
·
May 20, 2025
LSA has been named a Top Workplace by the Philadelphia Inquirer for the third straight year, showcasing its supportive and growth-focused environment. PA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Language Services Associates (LSA), a leader in …
Joseph Merola, MD, MMSc, and Alice Gottlieb, MD, PhD, Named Co-Scientific Advisors for HMP Global’s Dermatology Division
EIN Presswire
·
May 20, 2025
Collaboration will deliver expert insights on developments in dermatology; Merola and Gottlieb will also serve as Co-Chairs for Masterclasses in Dermatology MALVERN, PA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- HMP Global, the omnichannel …
Online Marketing for Doctors Delivers Exceptional Growth Results for Medical Professionals
GlobeNewswire
·
May 20, 2025
Online Marketing for Doctors empowers healthcare professionals worldwide to achieve rapid, measurable growth through specialized digital strategies. Their clients report major boosts in website traffic, patient inquiries, and marketing efficiency, while …
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
GlobeNewswire
·
May 20, 2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the “ …
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new Chief …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 20, 2025
NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44 …
Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
GlobeNewswire
·
May 20, 2025
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and …
Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
GlobeNewswire
·
May 20, 2025
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio invitro …
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
GlobeNewswire
·
May 20, 2025
SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient- …
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
GlobeNewswire
·
May 20, 2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable outlook; from BB. Fitch's report cites …
Neuphoria Provides First Quarter 2025 Business Updates
GlobeNewswire
·
May 20, 2025
Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s …
XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness
GlobeNewswire
·
May 20, 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport …
CooperCompanies’ 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet
GlobeNewswire
·
May 20, 2025
SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company’s initiatives to foster positive change for both …
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), le 20 mai, 2025 – GENFIT (Nasdaq et Euronext : GNFT), société́ biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares …
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
GlobeNewswire
·
May 20, 2025
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 20, 2025
SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …
INVO Fertility Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 20, 2025
SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Tactile Medical to Present at Upcoming Investor Conferences in June
GlobeNewswire
·
May 20, 2025
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be …